In this study, we sought to explore brain activity in nicotine-dependent men in response to
acute intravenous nicotine using pharmacological magnetic resonance imaging (phMRI).
Drug: Intravenous Nicotine
Other: Saline - placebo
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01588561
Ages eligible for Study
18 Years to 40 Years
Genders eligible for Study
Accepts Healthy Volunteers
Men and women between the ages of 18 and 40 who currently smoke at least 15 cigarettes every day, and who fulfill DSM-IV diagnostic criteria for nicotine dependence will be eligible for participation.
No evidence of clinically significant disease based upon complete medical history and physical examination by a qualified physician.
Absence of DSM-IV Axis I Disorders other than nicotine dependence (305.10) as measured by the Structured Clinical Interview (SCID).
Routine laboratory blood tests including complete blood count, electrolytes, BUN and creatinine, liver function tests, hepatitis panel and urinalysis will be performed. Laboratory parameters must be within the normal range. HBsAg must be negative but subjects who have hepatitis serology consistent with previous exposure to Hepatitis A, Hepatitis B, or Hepatitis C, but who do not have clinical and biochemical evidence of acute infection, will be acceptable.
Hematocrit levels ≥ 39% for males and ≥ 35% for females.
Serum pregnancy test (hCG beta subunit) results must be negative within 24 hrs of the study day.
A Body Mass Index (BMI—ratio of weight (W) to height (H) squared; W/H2=kg/m2) of between 18.0 and 27.0 for women and 21.4 to 29 for men.
Subjects must be able to read and understand instructions, as well as provide a valid informed consent.
Participants with any lifetime DSM-IV Axis I disorder other than nicotine dependence.
Participants with clinically significant medical disorders.
Women who are pregnant as determined by laboratory testing for serum beta hCG.
Women who use hormonal contraceptive medications will not be accepted, because this would confound the hormonal measures.
Women with a mean BMI of outside the range 18.0-27.0 and men with a BMI outside the range 21.4-29.0.
Participants with ferromagnetic implants or other contraindications to fMRI
Metal clips on blood vessels (also called stents)
Artificial heart valves
Artificial arms, hands, legs, etc.
Brain stimulator devices
Implanted drug pumps
Eye implants or known metal fragments in eyes
Exposure to shrapnel or metal filings (wounded in military combat, sheet metal workers, welders, and others)
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.